That's nice, ain't it?
Yeah, it's a PR email. 'Let's do it, boss!' All right, Voice, calm down.
Such enthusiasm!
Anyway ...
Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout investments, strengthens its team with the appointment of Dr. Edwin Moses and Jose Luis Martín as Operating Partners.
Okay. Fair enough.
Edwin Moses' appointment follows a very successful career as a biopharma entrepreneur, with decades of experience in building successful businesses. Among various achievements, he led the IPO for Ablynx and OAI (Oxford Asymmetry International), companies which he built and managed as CEO.
Right. What about Jose?
Jose Luis Martín was responsible for the development and implementation of corporate strategy at Werfen. For more than thirty years, he played a lead role in transforming the company from a local Spanish distributor to a large multinational company. The innovative firm is now a world leader in the In Vitro Diagnostics market with its products currently sold across more than 100 countries.
Okay. That's all right.
I just think it's a real shame that we'll never find out what Pierre Remy makes of these new developments. I mean, the arrival of these two operating partners. I mean ... that would be the cherry on top of the cake, that would. Just a few words. Just one little paragraph. 'Uh.' Telling us, Voice, telling the readers, telling the whole world ... what he really thinks. And his emotions, you know? I mean, we don't know. Pierre could be really upset that these two guys are working at Keensight now. He could be in despair. Sleepless nights? We don't know. I mean, they might be after his job. Christ. Who knows?! 'Boss, look -'
Pierre Remy, Managing Partner at Keensight Capital, said: "Following the arrival of Christophe Lavigne in June, we are thrilled to welcome two seasoned professionals such as Dr. Edwin Moses and Jose Luis Martín in our outstanding network of Operating Partners. Their exceptional track record in expanding companies globally will benefit Keensight as well as the talented managers of our portfolio companies, notably in the Healthcare sector, one of our chosen fields."
Oh, okay. 'He's thrilled.' They all are, son.
ENDS
...
Anything else?
What more can I say ... about anything? Everything has been said. All the thoughts in my head. And every feeling has been felt, yes.
I can't think no more. I can't even feel.
Is this silence? Is this peace?
